The 12th Qiming Venture Partners CEO Summit was held on 18th-20th November 2020 (China Time).
Since its debut in 2009, Qiming’s CEO Summit has been a flagship event aiming to facilitate communications among our portfolio CEOs, industry veterans, professional experts, and other thought leaders.
In the Healthcare session, founders and CEOs from each healthcare verticals will share insights and experiences - many for the first time - at the summit. Highlighted speakers include Mr. Zhongru Gan, Founder and Chairman of Gan & Lee Pharmaceuticals, and Mr. Xuefeng Yu, Chairman and CEO of CanSino Biologics Inc.
Day 3 Healthcare Track
20 November 2020
09:00—09:20 Opportunities and Trends in the Healthcare Sector
Nisa Leung, Managing Partner, Qiming Venture Partners
09:20—09:50 CEO Dialogues: How Does China’s Insulin Leader Innovate in the Global Market?
Zhongru Gan, Founder and Chairman, Gan & Lee Pharmaceuticals
Nisa Leung, Managing Partner, Qiming Venture Partners (Moderator)
09:50—10:20 CEO Dialogues: COVID-19 Vaccine Front-Runner CanSinoBio –Revealed
Xuefeng Yu, Chairman and CEO, CanSino Biologics Inc.
Shuo Qin, Founder, Commercial Civilization Research Center of China & Chin@ Moments (Moderator)
10:20—10:50 Scientists Dialogues: Gene Therapy-A Mover and Shaker in the Era of Biomedicine Revolution
Xiao Xiao, Chairman and CSO, Belief Biomed
Amy Tang, Venture Partner, Qiming Venture Partners (Moderator)
10:50—12:00 CEO Dialogues: Amid COVID-19: The Capacities of China’s Healthcare Companies
Yani Chen, CEO, Chain Medical Labs
Jinliang Ju, Founder, Chairman and Chief Scientist, Rendu Biotechnology
Kuan Chen, Founder and CEO, Infervision
William Hu, Managing Partner, Qiming Venture Partners (Moderator)
